The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Open accessAbstract
Primary Toxoplasma gondii infection is usually subclinical, but cervical lymphadenopathy or ocular disease can be present in some patients. Active infection is characterized by tachyzoites, while tissue cysts characterize latent disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foodborne illness acquired in the United States—Major pathogens
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.-A., Roy, S. L., Jones, J. L., & Griffin, P. M. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.p11101 · Cited by 7,657 · cited 6×
“Such an antenatal screening program has been implemented in France, where CT is less severe than that in the United States, where such a screening program does not exist (178).”
BackgroundInfluentialMontoya, J., & Liesenfeld, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16412-x · Cited by 3,232
Self-citationCouzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051 · cited 1×
“tors, including CTLA-4 as well as PD-1 in cancer and sepsis (239), its use in the form of”
BackgroundToxoplasmic Encephalitis in Patients With Acquired Immune Deficiency Syndrome
Luft, B. J. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350070031018 · Cited by 714
Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection
Denkers, E. Y., & Gazzinelli, R. T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.569 · Cited by 701
Clinical Practice: Management of Toxoplasma gondii Infection during Pregnancy
Montoya, J. G., & Remington, J. S. (2008) · Clinical Infectious Diseases · doi:10.1086/590149 · Cited by 690
Self-citationToxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome
Porter, S. B., & Sande, M. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272306 · Cited by 670
Gazzinelli, R., Xu, Y., Hieny, S., Cheever, A., & Sher, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.175 · Cited by 574
Vyas, A., Kim, S.-K., Giacomini, N., Boothroyd, J. C., & Sapolsky, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608310104 · Cited by 570
(2007) · The Lancet · doi:10.1016/s0140-6736(07)60072-5 · Cited by 542
Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii Infection
Guerina, N. G., Hsu, H.-W., Meissner, H. C., Maguire, J. H., Lynfield, R., Stechenberg, B., Abroms, I., Pasternack, M. S., Hoff, R., Eaton, R. B., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302604 · Cited by 505
Prenatal Management of 746 Pregnancies at Risk for Congenital Toxoplasmosis
Daffos, F., Forestier, F., Capella‐Pavlovsky, M., Thulliez, P., Aufrant, C., Valenti, D., & Cox, W. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802043180502 · Cited by 498
Development of Adverse Sequelae in Children Born with Subclinical Congenital Toxoplasma Infection
Wilson, C. B., Remington, J. S., Stagno, S., & Reynolds, D. W. (1980) · Pediatrics · doi:10.1542/peds.66.5.767 · Cited by 456
Sutterland, A. L., Fond, G., Kuin, A., Koeter, M. W. J., Lutter, R., van Gool, T., Yolken, R., Szoke, A., Leboyer, M., & de Haan, L. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12423 · Cited by 429
Clinical Manifestations of AIDS in the Era of Pneumocystis Prophylaxis
Hoover, D. R., Saah, A. J., Bacellar, H., Phair, J., Detels, R., Anderson, R., & Kaslow, R. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312233292604 · Cited by 406
Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome
Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D., Bosler, E. M., Bourland, D. D., Uttamchandani, R., Fuhrer, J., Jacobson, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291403 · Cited by 405
McAuley, J., Boyer, K. M., Patel, D., Mets, M., Swisher, C., Roizen, N., Wolters, C., Stein, L., Stein, M., Schey, W., et al. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.1.38 · Cited by 400
Prevention of toxoplasmosis in transplant patients
Derouin, F., & Pelloux, H. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02091.x · Cited by 365
Dannemann, B., McCutchan, J. A., Israelski, D., Antoniskis, D., Leport, C., Luft, B., Nussbaum, J., Clumeck, N., Morlat, P., Chiu, J., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-33 · Cited by 360
McLeod, R., Boyer, K., Karrison, T., Kasza, K., Swisher, C., Roizen, N., Jalbrzikowski, J., Remington, J., Heydemann, P., Noble, A. G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/501360 · Cited by 359
RESULTS OF 20-YEAR FOLLOW-UP OF CONGENITAL TOXOPLASMOSIS
Koppe, J. G., Loewer-Sieger, D. H., & DE ROEVER-BONNET, H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90785-3 · Cited by 354
Bosch-Driessen, L. E. H., Berendschot, T. T. J. M., Ongkosuwito, J. V., & Rothova, A. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00990-9 · Cited by 341
Demar, M., Ajzenberg, D., Maubon, D., Djossou, F., Panchoe, D., Punwasi, W., Valery, N., Peneau, C., Daigre, J.-L., Aznar, C., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/521246 · Cited by 338
Drugs in development for toxoplasmosis: advances, challenges, and current status
Alday, H., & Doggett, J. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s60973 · Cited by 321
Boyer, K. M., Holfels, E., Roizen, N., Swisher, C., Mack, D., Remington, J., Withers, S., Meier, P., McLeod, R., & the Toxoplasmosis Study Group (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.07.031 · Cited by 275
Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States
Maldonado, Y. A., Read, J. S., & COMMITTEE ON INFECTIOUS DISEASES (2017) · Pediatrics · doi:10.1542/peds.2016-3860 · Cited by 270
Katlama, C., De Wit, S., O'Doherty, E., Van Glabeke, M., Clumeck, N., & European Network for Treatment of AIDS (ENTA) Toxoplasmosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.268 · Cited by 253
Immunology of Toxoplasma gondii
Munoz, M., Liesenfeld, O., & Heimesaat, M. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00992.x · Cited by 239
Self-citationWallon, M., Peyron, F., Cornu, C., Vinault, S., Abrahamowicz, M., Kopp, C. B., & Binquet, C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit032 · Cited by 239
Ocular toxoplasmosis past, present and new aspects of an old disease
Maenz, M., Schlüter, D., Liesenfeld, O., Schares, G., Gross, U., & Pleyer, U. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.12.005 · Cited by 225
Self-citationAraujo, F. G., Huskinson, J., & Remington, J. S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.2.293 · Cited by 220
Cortina-Borja, M., Tan, H. K., Wallon, M., Paul, M., Prusa, A., Buffolano, W., Malm, G., Salt, A., Freeman, K., Petersen, E., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000351 · Cited by 214
Interleukin-12 enhances murine survival against acute toxoplasmosis
Khan, I. A., Matsuura, T., & Kasper, L. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.1639-1642.1994 · Cited by 196
Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis
Doggett, J. S., Nilsen, A., Forquer, I., Wegmann, K. W., Jones-Brando, L., Yolken, R. H., Bordón, C., Charman, S. A., Katneni, K., Schultz, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208069109 · Cited by 187
Therapy for Ocular Toxoplasmosis
Rothova, A., Meenken, C., Buitenhuis, H. J., Brinkman, C. J., Baarsma, G. S., Boen-Tan, T. N., de Jong, P. T. V. M., Klaassen-Broekema, N., Schweitzer, C. M. C., Timmerman, Z., et al. (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74456-3 · Cited by 179
Gras, L. A., Wallon, M., Pollak, A. J., Cortina‐Borja, M., Evengård, B., Hayde, M., Petersen, E., & Gilbert, R. E. (2005) · Acta Paediatrica · doi:10.1080/08035250500251999 · Cited by 178
Demar, M., Hommel, D., Djossou, F., Peneau, C., Boukhari, R., Louvel, D., Bourbigot, A. M., Nasser, V., Ajzenberg, D., Dardé, M., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03648.x · Cited by 168
Oral Infection of C57BL/6 Mice with Toxoplasma gondii:A New Model of Inflammatory Bowel Disease?
Liesenfeld, O. (2002) · The Journal of Infectious Diseases · doi:10.1086/338006 · Cited by 164
Self-citationMontazeri, M., Sharif, M., Sarvi, S., Mehrzadi, S., Ahmadpour, E., & Daryani, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00025 · Cited by 158
Toxoplasmosis, E. M. S. O. C., & Gras, L. A. (2003) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s1470-0328(02)02325-x · Cited by 152
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 140
Self-citationMaternal Serologic Screening to Prevent Congenital Toxoplasmosis: A Decision-Analytic Economic Model
Stillwaggon, E. M., Carrier, C. S., Sautter, M., & McLeod, R. L. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001333 · Cited by 135
Kirk, O., Reiss, P., Uberti‐Foppa, C., Bickel, M., Gerstoft, J., Pradier, C., Wit, F. W. N. M., Ledergerber, B., Lundgren, J. D., Furrer, H., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-4-200208200-00008 · Cited by 134
Sauer, I., Dunay, I. R., Weisgraber, K. H., Bienert, M., & Dathe, M. (2005) · Biochemistry · doi:10.1021/bi048080x · Cited by 131
Self-citationGilbert, R. E., Gras, L. A., Wallon, M., Peyron, F., Ades, A. E., & Dunn, D. T. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.6.1303 · Cited by 131
Vogel, N., Kirisits, M., Michael, E., Bach, H., Hostetter, M. K., Boyer, K. M., Simpson, R. J., Holfels, E., Hopkins, J., Mack, D., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.1055 · Cited by 130
Intervention Strategies to Reduce Human Toxoplasma gondii Disease Burden
Opsteegh, M., Kortbeek, T., Havelaar, A. H., & van der Giessen, J. W. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu721 · Cited by 127
Antibiotics for human toxoplasmosis: a systematic review of randomized trials
Rajapakse, S., Shivanthan, M. C., Samaranayake, N., Rodrigo, C., & Fernando, S. D. (2013) · Pathogens and Global Health · doi:10.1179/2047773213y.0000000094 · Cited by 118
Taylor, G. A., Feng, C. G., & Sher, A. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.09.004 · Cited by 115
Behnke, M. S., Khan, A., Lauron, E. J., Jimah, J. R., Wang, Q., Tolia, N. H., & Sibley, L. D. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005434 · Cited by 109
Treatments for toxoplasmosis in pregnancy
Peyron, F., Wallon, M., Liou, C., & Garner, P. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001684 · Cited by 102
Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving
Prusa, A., Kasper, D. C., Sawers, L., Walter, E., Hayde, M., & Stillwaggon, E. M. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005648 · Cited by 98
Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States
Dhakal, R., Gajurel, K., Pomares-Estran, C., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01663-15 · Cited by 96
Self-citationGras, L. A., Gilbert, R. E., Ades, A. E., & Dunn, D. T. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.6.1309 · Cited by 95
Vidadala, R. S. R., Rivas, K. L., Ojo, K. K., Hulverson, M. A., Zambriski, J. A., Bruzual, I., Schultz, T. L., Huang, W., Zhang, Z., Scheele, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00760 · Cited by 93
Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection
Tedford, E., & McConkey, G. A. (2017) · Pathogens · doi:10.3390/pathogens6020019 · Cited by 91
Treatment of Toxoplasmic Encephalitis With Intravenous Clindamycin
Dannemann, B. R. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.11.2477 · Cited by 89
Meers, S., Lagrou, K., Theunissen, K., Dierickx, D., Delforge, M., Devos, T., Janssens, A., Meersseman, W., Verhoef, G. E. G., Eldere, J. V., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651266 · Cited by 85
Intravitreal Clindamycin and Dexamethasone for Toxoplasmic Retinochoroiditis
Kishore, K., Conway, M. D., & Peyman, G. A. (2001) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/1542-8877-20010501-03 · Cited by 84
Lifelong Persistence of Toxoplasma Cysts: A Questionable Dogma?
Rougier, S., Montoya, J. G., & Peyron, F. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.10.007 · Cited by 84
Self-citationLieberman, L. A., & Hunter, C. A. (2002) · International Reviews of Immunology · doi:10.1080/08830180213281 · Cited by 78
Rutaganira, F. U., Barks, J., Dhason, M. S., Wang, Q., Lopez, M. S., Long, S., Radke, J. B., Jones, N. G., Maddirala, A. R., Janetka, J. W., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01192 · Cited by 76
Cohn, D. L., Fisher, E. J., Peng, G., Hodges, J. S., Chesnut, J., Child, C. C., Franchino, B., Gibert, C. L., El‐Sadr, W., Hafner, R., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520141 · Cited by 74
Fernández‐Ruiz, M., Meije, Y., Manuel, O., Akan, H., Carratalà, J., Aguado, J. M., & Delaloye, J. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.029 · Cited by 74
Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon
Suzuki, Y., Conley, F. K., & Remington, J. S. (1990) · Infection and Immunity · doi:10.1128/iai.58.9.3050-3055.1990 · Cited by 72
Djawe, K., Buchacz, K. A., Hsu, L. C., Chen, M.-J., Selik, R. M., Rose, C. E., Williams, T., Brooks, J. T., & Schwarcz, S. K. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv235 · Cited by 70
In Vitro Assessment of Antimicrobial Agents Against Toxoplasma gondii
Harris, C., Salgo, M., Tanowitz, H. B., & Wittner, M. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/157.1.14 · Cited by 70
Shubar, H. M., Lachenmaier, S., Heimesaat, M. M., Lohman, U., Mauludın, R., Mueller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2010) · Journal of drug targeting · doi:10.3109/10611861003733995 · Cited by 69
Self-citationDunay, I. R., Heimesaat, M. M., Bushrab, F. N., Müller, R. H., Stocker, H., Arastéh, K., Kurowski, M., Fitzner, R., Borner, K., & Liesenfeld, O. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4848-4854.2004 · Cited by 68
Self-citationGuanabenz Repurposed as an Antiparasitic with Activity against Acute and Latent Toxoplasmosis
Benmerzouga, I., Checkley, L. A., Ferdig, M. T., Arrizabalaga, G., Wek, R. C., & Sullivan, W. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01683-15 · Cited by 66
Treatment of Ocular Toxoplasmosis with Clindamycin and Sulfadiazine
Tabbara, K. F., & O’Connor, G. R. (1980) · Ophthalmology · doi:10.1016/s0161-6420(80)35268-8 · Cited by 64
Suzuki, Y., Kang, H., Parmley, S. F., et al. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00318-x · Cited by 59
Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity
McFarland, M. M., Zach, S. J., Wang, X., Potluri, L., Neville, A. J., Vennerstrom, J. L., & Davis, P. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01176-16 · Cited by 54
Shubar, H. M., Dunay, I. R., Lachenmaier, S., Dathe, M., Bushrab, F. N., Mauludın, R., Müller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2009) · Journal of drug targeting · doi:10.1080/10611860902718680 · Cited by 37
Self-citationGet Rich Quick With Old Generic Drugs! The Pyrimethamine Pricing Scandal
Gallant, J. E. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv177 · Cited by 37
Ocular toxoplasmosis in pregnancy
Kump, L. I., Androudi, S. N., & Foster, C. (2005) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2005.01061.x · Cited by 36
Latent Toxoplasmosis gondii: Emerging Evidence for Influences on Neuropsychiatric Disorders
Hurley, R. A., & Taber, K. H. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12100234 · Cited by 32
Connolly, M. P., Goodwin, E., Schey, C., & Zummo, J. (2017) · Pathogens and Global Health · doi:10.1080/20477724.2016.1273597 · Cited by 24
Berghold, C., Herzog, S. A., Jakse, H., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.33.30317 · Cited by 23
Borkowski, P. K., Brydak-Godowska, J. E., Wojciech, B., Karolina, Ś., Hanna, Ż.-P., Maria, O.-K., Piotr, K., & Rabczenko, D. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004892 · Cited by 21
de Souza, C. E., Nascimento, H., Filho, A. A. D. S. L., Muccioli, C., & Belfort, R. (2017) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2017.1307420 · Cited by 19
Cited by
Control of human toxoplasmosis
Smith, N. C., Goulart, C., Hayward, J. A., Kupz, A., Miller, C. M., & van Dooren, G. G. (2021) · International Journal for Parasitology · doi:10.1016/j.ijpara.2020.11.001 · Cited by 286
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis
Elsheikha, H. M., Marra, C. M., & Zhu, X.-Q. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-19 · Cited by 262
Toxoplasma gondii infection and its implications within the central nervous system
Matta, S. K., Rinkenberger, N., Dunay, I. R., & Sibley, L. D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00518-7 · Cited by 261
Self-citationAdvances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development
Chu, K.-B., & Quan, F.-S. (2021) · Vaccines · doi:10.3390/vaccines9050413 · Cited by 92
Toxoplasmosis vaccines: what we have and where to go?
Zhang, Y., Li, D., Lu, S., & Zheng, B. (2022) · npj Vaccines · doi:10.1038/s41541-022-00563-0 · Cited by 77
Metadata
- Authors
- Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O., & Montoya, J. G.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2018-10
- Volume
- 31
- Issue
- 4
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2889776706
- Cited by
- 553
- References
- 82
- FWCI
- 28.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.